US mulls tar­iffs on Swiss drug ex­ports, weigh­ing on No­var­tis and Roche –  re­port

The lead­ing Swiss news­pa­per has re­port­ed that the US is con­sid­er­ing plac­ing tar­iffs on phar­ma­ceu­ti­cals from Switzer­land. Roche and No­var­tis stock each fell 1% af­ter the news broke.

Neue Zürcher Zeitung re­port­ed that US Trade Rep­re­sen­ta­tive Robert Lighthiz­er told phar­ma­ceu­ti­cal rep­re­sen­ta­tives the Trump ad­min­is­tra­tion was con­sid­er­ing the move. Tar­iffs do not ap­pear to be in the im­me­di­ate off­ing, but they would po­ten­tial­ly af­fect Swiss gi­ants No­var­tis and Roche along with oth­er com­pa­nies that man­u­fac­ture in Switzer­land, in­clud­ing Mer­ck KGaA and US biotech Bio­gen, which is cur­rent­ly con­struct­ing a new fa­cil­i­ty in the coun­try.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER